The Scientist

» cancer, neuroscience and disease/medicine

Most Recent

image: First CRISPR Clinical Trial Commences

First CRISPR Clinical Trial Commences

By | November 15, 2016

Scientists in China aim to treat 10 people with lung cancer with CRISPR-edited cells.

0 Comments

image: Probing Exercise’s Effects on Cognitive Function

Probing Exercise’s Effects on Cognitive Function

By | November 14, 2016

Researchers at the Society for Neuroscience discuss what we know—and don’t—about how physical activity affects the brain.

1 Comment

image: Rats Are Ticklish, Sometimes

Rats Are Ticklish, Sometimes

By | November 14, 2016

Researchers may have pinpointed the part of the brain that makes rats laugh when tickled.

0 Comments

image: Amyloid Designed to Inactivate Cancer-Related Protein

Amyloid Designed to Inactivate Cancer-Related Protein

By | November 14, 2016

Researchers build a peptide that causes a receptor to form toxic, amyloid-like clumps in cells.

0 Comments

image: Barcoding the Connectome

Barcoding the Connectome

By | November 11, 2016

Watch how researchers use RNA to track where neurons' axons end in the mouse brain.

0 Comments

image: More Success Fixing Sickle Cell Gene with CRISPR

More Success Fixing Sickle Cell Gene with CRISPR

By | November 9, 2016

Researchers say they have sufficient in vitro and animal data to apply for human testing.

0 Comments

image: Five Oncoviruses Debut On NIH Carcinogen List

Five Oncoviruses Debut On NIH Carcinogen List

By | November 7, 2016

Seven newly evaluated substances, including five oncoviruses, have been added to the US National Institutes of Health’s 14th Report on Carcinogens.

0 Comments

image: Smoking-Linked Cancer Mutations Mapped

Smoking-Linked Cancer Mutations Mapped

By | November 3, 2016

Scientists produce a detailed genomic map of mutations and epigenetic changes associated with smoking tobacco across 17 tumor types. 

1 Comment

image: New Support for Experimental Alzheimer’s Drug

New Support for Experimental Alzheimer’s Drug

By | November 2, 2016

Merck’s verubecestat, which is currently being tested in two Phase 3 studies, is safe, according to newly published Phase 1 data.

2 Comments

Family members with a certain gene variant had unnecessary interventions, highlighting the potential hazards of precision medicine.

2 Comments

Popular Now

  1. Broad Wins CRISPR Patent Interference Case
    Daily News Broad Wins CRISPR Patent Interference Case

    The USPTO’s Patent Trial and Appeal Board has ruled in favor of the Broad Institute of MIT and Harvard retaining intellectual property rights covered by its patents for CRISPR gene-editing technology.

  2. Henrietta Lacks’s Family Seeks Compensation
  3. Cannibalism: Not That Weird
    Reading Frames Cannibalism: Not That Weird

    Eating members of your own species might turn the stomach of the average human, but some animal species make a habit of dining on their own.

  4. Can Plants Learn to Associate Stimuli with Reward?
Business Birmingham